Ursprung des Netzwerks ersten Grades von Dean Morris
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Roslin Cell Therapies Ltd. is a leading contract development and manufacturing services organization focused on advanced cell and gene therapies. The company was established in 2006 and is based in Edinburgh, UK. and has subsidiaries in the United States. Roslin Cell Therapies has a remarkable heritage in the field, having been among the first in the world to produce clinical-grade human pluripotent stem cells and advancing the first CRISPR edited stem cell-based therapy for a major disease to marketing authorization. The British company provides innovative process and analytical development, CGMP clinical and commercial manufacturing for a range of cell types, and CGMP iPSC cell line development, gene editing, and differentiation. With tailored CDMO solutions, Roslin Cell Therapies enables partners to efficiently progress from development to commercialization and deliver life-saving cell and gene therapies worldwide. Peter Alistair Coleman has been the CEO of the company since 2022.
7
| Holding Company | Biotechnology | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Dean Morris
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
DOW CHEMICAL COMPANY (THE) | Chemicals: Specialty | Corporate Officer/Principal | |
REPLIGEN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Chairman | |
THE CHARACTER GROUP PLC | Recreational Products | Director/Board Member | |
Cobra Biologics Holdings Ltd.
Cobra Biologics Holdings Ltd. BiotechnologyHealth Technology Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Collaborative BioAlliance Inc & Collaborative Smithfield Corp
Collaborative BioAlliance Inc & Collaborative Smithfield Corp Pharmaceuticals: MajorHealth Technology Part of Dow, Inc., Collaborative BioAlliance Inc & Collaborative Smithfield Corp is an American company that develops and manufactures biopharmaceutical drugs. The company is based in NY. Collaborative BioAlliance Inc & Collaborative Smithfield was acquired by The Dow Chemical Co., a SUB of Dow, Inc. from Engelhard Long Island, Inc. on November 17, 2000. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Premium TV Ltd.
Premium TV Ltd. Miscellaneous Commercial ServicesCommercial Services Premium TV Ltd. acquires, promotes, develops media, sporting rights and interests. It broadcasts different sports and events through its channels. The company is located in London, UK. | Miscellaneous Commercial Services | Chief Executive Officer | |
Villanova University | College/University | Undergraduate Degree | |
3i Private Equity
3i Private Equity Investment ManagersFinance 3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world. | Investment Managers | Private Equity Investor | |
Dowpharma
Dowpharma Chemicals: SpecialtyProcess Industries Dowpharma Manufactures and distributes chemical, pharmaceutical, and biopharmaceutical products. It offers nucleic acid medicines, peptides, and ChelaMed radiopharmaceutical products. The company is headquartered in Cambridge, UK. | Chemicals: Specialty | Corporate Officer/Principal | |
CellCarta Biosciences, Inc.
CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services CellCarta Biosciences, Inc. develops proteomics and immune monitoring services. The firm offers integrated platforms in proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. Its services include biomarker discovery, cell engine software, cellular enumeration, clinical laboratory services, functional profiling, host cell proteins detection, phenotyping characterization and receptor occupancy. The company was founded by Martin LeBlanc in 2000 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
PFENEX INC. | Biotechnology | Chief Executive Officer | |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Oncimmune Ltd. provides clinical testing services for cancer detection. The firm develops early cancer detection tests for lung, breast, colorectal, prostate, stomach, pancreatic and ovarian cancers. The company was founded by John F. R. Robertson in 2003 and is headquartered in Nottingham, the United Kingdom. | Biotechnology | Director/Board Member | |
Abingdon Management Co. Ltd.
Abingdon Management Co. Ltd. Real Estate DevelopmentFinance Abingdon Management Co. Ltd. provides real estate services. | Real Estate Development | Director/Board Member | |
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
ONCIMMUNE HOLDINGS PLC | Biotechnology | Chairman | |
Caprion Proteomics, Inc.
Caprion Proteomics, Inc. Medical SpecialtiesHealth Technology Caprion Proteomics, Inc. provides proteomics and immune monitoring services to the pharmaceutical and biotechnology industry. It specializes in proteomics, biomarkers, discovery, validation, services, immune monitoring, flow cytometry and elispot areas. The company was founded by Neil Cashman and Martin LeBlanc in 2000 and is headquartered in Montreal, Canada. | Medical Specialties | Director/Board Member | |
Watch Bidco Ltd.
Watch Bidco Ltd. Financial ConglomeratesFinance Watch Bidco Ltd. functions as an investment holding British company. The private company is based in Ruddington, UK. | Financial Conglomerates | Director/Board Member | |
Quotient Sciences (Reading) Ltd.
Quotient Sciences (Reading) Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences (Reading) Ltd. develops preclinical and early phase formulations and manufactures clinical trials materials. It engages in optimization of drug substance physical forms (salt, polymorphs and co-crystals), the development of preclinical and early phase formulations and the manufacture of clinical trial materials. The company was founded by Graham Buckton in January 2000 and is headquartered in Reading, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Censo Biotechnologies Ltd.
Censo Biotechnologies Ltd. Miscellaneous Commercial ServicesCommercial Services Censo Biotechnologies Ltd. operates as stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. It offers human bio-sample procurement, IPSC generation & genome editing, IPSC differentiation, assay development and screening services. The company is headquartered in Midlothian, the United Kingdom. | Miscellaneous Commercial Services | Chief Operating Officer | |
Lykan Bioscience LLC
Lykan Bioscience LLC Pharmaceuticals: MajorHealth Technology Lykan Bioscience LLC provides outsourced end-to-end production and logistics solutions for pharmaceutical and biotech companies focused on cell and gene therapies. The company was founded by Anthony Rotunno and is headquartered in Hopkinton, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Watch Midco 1 Ltd.
Watch Midco 1 Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Watch Midco 1 Ltd. functions as an investment holding British company. The company is based in Ruddington, UK and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
Quotient Sciences Holdings Ltd.
Quotient Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Watch Topco Ltd., Quotient Sciences Holdings Ltd. is an investment holding British company. The company is based in Nottingham, UK. Quotient Sciences Holdings was founded in 2015. | Financial Conglomerates | Director/Board Member | |
Envision Pharma Bidco Ltd.
Envision Pharma Bidco Ltd. Financial ConglomeratesFinance Part of Envision Pharma, Inc., Envision Pharma Bidco Ltd. functions as an investment holding British company. The company is based in Horsham, UK and was founded in 2016. | Financial Conglomerates | Director/Board Member | |
Envision Pharma Midco Ltd.
Envision Pharma Midco Ltd. Financial ConglomeratesFinance Founded in 2016, Envision Pharma Midco Ltd. is a British company that functions as an investment holding company. Part of Envision Pharma, Inc., the company is based in Horsham, UK. | Financial Conglomerates | Director/Board Member | |
Iris Topco (UK) Ltd.
Iris Topco (UK) Ltd. Medical DistributorsDistribution Services Part of GHO Capital Partners LLP, Iris Topco (UK) Ltd. is a holding British company that distributes pharmaceutical goods and medical devices. The company is based in London, UK and was founded in 2016. | Medical Distributors | Director/Board Member | |
Silver Topco GmbH
Silver Topco GmbH Financial ConglomeratesFinance Silver Topco GmbH is an investment holding German company. The private company is based in Jena, Germany. The CEOs are Michael Turner, Alan Browning MacKay. The company was founded in 2018. | Financial Conglomerates | Chief Executive Officer | |
GHO Capital Ltd.
GHO Capital Ltd. Financial ConglomeratesFinance Part of GHO Capital Partners LLP, GHO Capital Ltd. functions as an investment holding British company. The company is based in London, UK. It was founded in 2013. | Financial Conglomerates | Director/Board Member | |
Mint Holdco UK Ltd.
Mint Holdco UK Ltd. Financial ConglomeratesFinance Mint Holdco UK Ltd. operates as a financial services holding firm. The company was founded on December 11, 2019 and is headquartered in Fareham, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Envision Pharma Trustee Ltd.
Envision Pharma Trustee Ltd. Engineering & ConstructionIndustrial Services Part of Envision Pharma, Inc., Envision Pharma Trustee Ltd. is a British company that provides professional, scientific and technical activities. The company is based in Horsham, UK and was founded in 2016. | Engineering & Construction | Director/Board Member | |
Quotient Sciences Ltd.
Quotient Sciences Ltd. Pharmaceuticals: MajorHealth Technology Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Hermes GPE LLP
Hermes GPE LLP Investment ManagersFinance Hermes GPE LLP (Hermes GPE), a subsidiary of Hermes Fund Managers Ltd founded in 1983. The firm is headquartered in London with additional offices in Singapore and New York. | Investment Managers | Chief Executive Officer | |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners LLP (GHO Capital Partners) is a private equity firm founded in 2014 by Mireille G. Gillings, Dennis B. Gillings, Alan Browning MacKay, Michael Irvine Mortimer and Andrea Ponti. The firm is headquartered in London, United Kingdom. | Investment Managers | Founder Founder Private Equity Investor |
Statistik
International
Vereinigtes Königreich | 26 |
Vereinigte Staaten | 8 |
Kanada | 3 |
Schweden | 2 |
Deutschland | 2 |
Sektoral
Finance | 14 |
Health Technology | 13 |
Commercial Services | 5 |
Process Industries | 3 |
Health Services | 2 |
Operativ
Director/Board Member | 26 |
Chief Executive Officer | 11 |
Corporate Officer/Principal | 6 |
Chairman | 5 |
Private Equity Investor | 4 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Dean Morris
- Unternehmensverbindungen